RecruitingNCT06537921
A feasibility study of minocycline for depression with obesity
About this title
Read the official source — NCT06537921Medication studyAges 18–65United Kingdom
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
Participants take minocycline capsules alongside their usual antidepressant. The protocol specifies eight weeks of this study medication.
- Listed locations
- LondonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 35
- Sponsor
- King's College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United Kingdom
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06537921
- Official title
Show the full official title
Feasibility Study in Comorbid Obesity and Treatment-Resistant Depression Using Minocycline as Adjunctive Treatment (CODA)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
London
Interested in joining this study?
Questions about this study
What will I need to do?
You will take study medication.
Who is behind this study?
The study sponsor is King's College London, a university.
Does this study involve medication?
Yes. The study involves medication, including Minocycline 200mg.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
